CETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials

Journal of Lipid Research

Volumn 56, Issue 3, 2015, Pages 713-721

  Qi, Qibin ^a,b   Durst, Ronen ^c   Schwarzfuchs, Dan ^d   Leitersdorf, Eran ^c   Shpitzen, Shoshi ^c   Li, Yanping ^b   Wu, Hongyu ^b   Champagne, Catherine M ^e   Hu, Frank B ^b,f   Stampfer, Meir J ^b,f   Bray, George A ^e   Sacks, Frank M ^b   Shai, Iris ^g   Qi, Lu ^b,f  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d NUCLEAR RESEARCH CENTER NEGEV   (Israel)

^e PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cholesteryl ester transfer protein; Dietary intervention randomized controlled trial; Gene diet interaction; Preventing overweight using novel dietary strategies

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; CETP PROTEIN, HUMAN; FAT INTAKE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CETP GENE; CONTROLLED STUDY; FAT CONTENT; FEMALE; GENE; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; LIPID DIET; LOW CARBOHYDRATE DIET; LOW FAT DIET; MALE; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; ADMINISTRATION AND DOSAGE; AGED; BLOOD; CLINICAL TRIAL; DIET THERAPY; FAT INTAKE; FOLLOW UP; GENETICS; MIDDLE AGED; MULTICENTER STUDY;

ADULT; AGED; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; DIETARY FATS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY; TRIGLYCERIDES; WEIGHT LOSS;

EID: 84925340970     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P055715     Document Type: Article

References (44)

1. Lewington, S., G. Whitlock, R. Clarke, P. Sherliker, J. Emberson, J. Halsey, N. Qizilbash, R. Peto, and R. Collins. 2007. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 370: 1829-1839.
2. Sarwar, N., J. Danesh, G. Eiriksdottir, G. Sigurdsson, N. Wareham, S. Bingham, S. M. Boekholdt, K. T. Khaw, and V. Gudnason. 2007. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 115: 450-458.
3. Di Angelantonio, E., N. Sarwar, P. Perry, S. Kaptoge, K. K. Ray, A. Thompson, A. M. Wood, S. Lewington, N. Sattar, C. J. Packard, et al. 2009. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 302: 1993-2000.
4. Costanza, M. C., E. Cayanis, B. M. Ross, M. S. Flaherty, G. B. Alvin, K. Das, and A. Morabia. 2005. Relative contributions of genes, environment, and interactions to blood lipid concentrations in a general adult population. Am. J. Epidemiol. 161: 714-724.
5. Ordovas, J. M., and A. H. Shen. 2002. Genetics, the environment, and lipid abnormalities. Curr. Cardiol. Rep. 4: 508-513.
6. Tall, A. R. 1986. Plasma lipid transfer proteins. J. Lipid Res. 27: 361-367.
7. Brown, M. L., A. Inazu, C. B. Hesler, L. B. Agellon, C. Mann, M. E. Whitlock, Y. L. Marcel, R. W. Milne, J. Koizumi, H. Mabuchi, et al. 1989. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 342: 448-451.
8. Inazu, A., M. L. Brown, C. B. Hesler, L. B. Agellon, J. Koizumi, K. Takata, Y. Maruhama, H. Mabuchi, and A. R. Tall. 1990. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N. Engl. J. Med. 323: 1234-1238.
9. Brousseau, M. E., E. J. Schaefer, M. L. Wolfe, L. T. Bloedon, A. G. Digenio, R. W. Clark, J. P. Mancuso, and D. J. Rader. 2004. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N. Engl. J. Med. 350: 1505-1515.
10. Thompson, A., E. Di Angelantonio, N. Sarwar, S. Erqou, D. Saleheen, R. P. Dullaart, B. Keavney, Z. Ye, and J. Danesh. 2008. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA. 299: 2777-2788.
11. Boekholdt, S. M., F. M. Sacks, J. W. Jukema, J. Shepherd, D. J. Freeman, A. D. McMahon, F. Cambien, V. Nicaud, G. J. de Grooth, P. J. Talmud, et al. 2005. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation. 111: 278-287.
12. Fumeron, F., D. Betoulle, G. Luc, I. Behague, S. Ricard, O. Poirier, R. Jemaa, A. Evans, D. Arveiler, P. Marques-Vidal, et al. 1995. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Invest. 96: 1664-1671.
13. Tsujita, Y., Y. Nakamura, Q. S. Zhang, S. Tamaki, A. Nozaki, K. Amamoto, T. Kadowaki, Y. Kita, T. Okamura, M. Horie, et al. 2007. The association between high-density lipoprotein cholesterol level and cholesteryl ester transfer protein TaqIB gene polymorphism is influenced by alcohol drinking in a population-based sample. Atherosclerosis. 191: 199-205.
14. Jensen, M. K., K. J. Mukamal, K. Overvad, and E. B. Rimm. 2008. Alcohol consumption, TaqIB polymorphism of cholesteryl ester transfer protein, high-density lipoprotein cholesterol, and risk of coronary heart disease in men and women. Eur. Heart J. 29: 104-112.
15. Li, T. Y., C. Zhang, F. W. Asselbergs, L. Qi, E. Rimm, D. J. Hunter, and F. B. Hu. 2007. Interaction between dietary fat intake and the cholesterol ester transfer protein TaqIB polymorphism in relation to HDL-cholesterol concentrations among US diabetic men. Am. J. Clin. Nutr. 86: 1524-1529.
16. Corella, D., P. Carrasco, M. Fito, M. A. Martinez-Gonzalez, J. Salas-Salvado, F. Aros, J. Lapetra, M. Guillen, C. Ortega-Azorin, J. Warnberg, et al. 2010. Gene-environment interactions of CETP gene variation in a high cardiovascular risk Mediterranean population. J. Lipid Res. 51: 2798-2807.
17. Corella, D., C. Saiz, M. Guillen, O. Portoles, F. Mulet, J. I. Gonzalez, and J. M. Ordovas. 2000. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. Atherosclerosis. 152: 367-376.
18. Chen, J., T. Yokoyama, K. Saito, N. Yoshiike, C. Date, and H. Tanaka. 2002. Association of Human Cholesteryl Ester Transfer Protein-Tagl Polymorphisms with Serum HDL Cholesterol Levels in a Normolipemic Japanese Rural Population. J. Epidemiol. 12: 77-84.
19. Talmud, P. J., E. Hawe, K. Robertson, G. J. Miller, N. E. Miller, and S. E. Humphries. 2002. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men. Ann. Hum. Genet. 66: 111-124.
20. Nettleton, J. A., L. M. Steffen, C. M. Ballantyne, E. Boerwinkle, and A. R. Folsom. 2007. Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adults. Atherosclerosis. 194: e131-e140.
21. Carmena-Ramón, R., J. F. Ascaso, J. T. Real, G. Njera, J. M. Ordovs, and R. Carmena. 2001. Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and plasma lipoprotein levels in familial hypercholesterolemia. Metabolism. 50: 651-656.
22. Aitken, W. A. E., A. W. A. H. Chisholm, A. W. Duncan, M. J. Harper, S. E. Humphries, J. I. Mann, C. Murray Skeaff, W. H. F. Sutherland, A. J. Wallace, and S. M. Williams. 2006. Variation in the cholesteryl ester transfer protein (CETP) gene does not influence individual plasma cholesterol response to changes in the nature of dietary fat. Nutr. Metab. Cardiovasc. Dis. 16: 353-363.
23. Willer, C. J., S. Sanna, A. U. Jackson, A. Scuteri, L. L. Bonnycastle, R. Clarke, S. C. Heath, N. J. Timpson, S. S. Najjar, H. M. Stringham, et al. 2008. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40: 161-169.
24. Kathiresan, S., O. Melander, C. Guiducci, A. Surti, N. P. Burtt, M. J. Rieder, G. M. Cooper, C. Roos, B. F. Voight, A. S. Havulinna, et al. 2008. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40: 189-197.
25. Kathiresan, S., C. J. Willer, G. M. Peloso, S. Demissie, K. Musunuru, E. E. Schadt, L. Kaplan, D. Bennett, Y. Li, T. Tanaka, et al. 2009. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41: 56-65.
26. Aulchenko, Y. S., S. Ripatti, I. Lindqvist, D. Boomsma, I. M. Heid, P. P. Pramstaller, B. W. Penninx, A. C. Janssens, J. F. Wilson, T. Spector, et al. 2009. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 41: 47-55.
27. Teslovich, T. M., K. Musunuru, A. V. Smith, A. C. Edmondson, I. M. Stylianou, M. Koseki, J. P. Pirruccello, S. Ripatti, D. I. Chasman, C. J. Willer, et al. 2010. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 466: 707-713.
28. Sacks, F. M., G. A. Bray, V. J. Carey, S. R. Smith, D. H. Ryan, S. D. Anton, K. McManus, C. M. Champagne, L. M. Bishop, N. Laranjo, et al. 2009. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N. Engl. J. Med. 360: 859-873.
29. Shai, I., D. Schwarzfuchs, Y. Henkin, D. R. Shahar, S. Witkow, I. Greenberg, R. Golan, D. Fraser, A. Bolotin, H. Vardi, et al. 2008. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N. Engl. J. Med. 359: 229-241.
30. Qi, Q., G. A. Bray, F. B. Hu, F. M. Sacks, and L. Qi. 2012. Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial. Am. J. Clin. Nutr. 95: 506-513.
31. Qi, Q., G. A. Bray, S. R. Smith, F. B. Hu, F. M. Sacks, and L. Qi. 2011. Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation. 124: 563-571.
32. Klerkx, A. H. E. M., M. W. T. Tanck, J. J. P. Kastelein, H. O. F. Molhuizen, J. W. Jukema, A. H. Zwinderman, and J. A. Kuivenhoven. 2003. Haplotype analysis of the CETP gene: not TaqIB, but the closely linked-629C -> A polymorphism and a novel promoter variant are independently associated with CETP concentration. Hum. Mol. Genet. 12: 111-123.
33. Papp, A. C., J. K. Pinsonneault, D. Wang, L. C. Newman, Y. Gong, J. A. Johnson, C. J. Pepine, M. Kumari, A. D. Hingorani, P. J. Talmud, et al. 2012. Cholesteryl ester transfer protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular risk. PLoS ONE. 7: e31930.
34. Blüher, M., A. Rudich, N. Klöting, R. Golan, Y. Henkin, E. Rubin, D. Schwarzfuchs, Y. Gepner, M. J. Stampfer, M. Fiedler, et al. 2012. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care. 35: 342-349.
35. Son, Y. S., and D. B. Zilversmit. 1986. Increased lipid transfer activities in hyperlipidemic rabbit plasma. Arteriosclerosis. 6: 345-351.
36. McPherson, R., P. Lau, P. Kussie, H. Barrett, and A. R. Tall. 1997. Plasma kinetics of cholesteryl ester transfer protein in the rabbit. Effects of dietary cholesterol. Arterioscler. Thromb. Vasc. Biol. 17: 203-210.
37. Quinet, E., A. Tall, R. Ramakrishnan, and L. Rudel. 1991. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J. Clin. Invest. 87: 1559-1566.
38. Fusegawa, Y., K. L. Kelley, J. K. Sawyer, R. N. Shah, and L. L. Rudel. 2001. Influence of dietary fatty acid composition on the relationship between CETP activity and plasma lipoproteins in monkeys. J. Lipid Res. 42: 1849-1857.
39. Gupta, S. V., N. Yamada, T. V. Fungwe, and P. Khosla. 2003. Replacing 40% of dietary animal fat with vegetable oil is associated with lower HDL cholesterol and higher cholesterol ester transfer protein in cynomolgus monkeys fed sufficient linoleic acid. J. Nutr. 133: 2600-2606.
40. Cheema, S. K., A. Agarwal-Mawal, C. M. Murray, and S. Tucker. 2005. Lack of stimulation of cholesteryl ester transfer protein by cholesterol in the presence of a high-fat diet. J. Lipid Res. 46: 2356-2366.
41. Groener, J. E., E. M. van Ramshorst, M. B. Katan, R. P. Mensink, and A. van Tol. 1991. Diet-induced alteration in the activity of plasma lipid transfer protein in normolipidemic human subjects. Atherosclerosis. 87: 221-226.
42. Schwab, U. S., H. M. Maliranta, E. S. Sarkkinen, M. J. Savolainen, Y. A. Kesaniemi, and M. I. Uusitupa. 1996. Different effects of palmitic and stearic acid-enriched diets on serum lipids and lipoproteins and plasma cholesteryl ester transfer protein activity in healthy young women. Metabolism. 45: 143-149.
43. Jansen, S., J. Lopez-Miranda, P. Castro, F. Lopez-Segura, C. Marin, J. M. Ordovas, E. Paz, J. Jimenez-Pereperez, F. Fuentes, and F. Perez-Jimenez. 2000. Low-fat and high-monounsaturated fatty acid diets decrease plasma cholesterol ester transfer protein concentrations in young, healthy, normolipemic men. Am. J. Clin. Nutr. 72: 36-41.
44. Eckel, R. H., J. M. Jakicic, J. D. Ard, J. M. de Jesus, N. Houston Miller, V. S. Hubbard, I. M. Lee, A. H. Lichtenstein, C. M. Loria, B. E. Millen, et al. 2014. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 129: S76-S99.